When studied as PrEP | |
When studied as part of a multidrug HIV treatment regimen | Lactic acidosis Severe hepatomegaly with steatosis Posttreatment exacerbation of hepatitis B New or worsening renal failure Decreased serum phosphorus Bone loss without associated fracture risk
|